Erythromycin Ethylsuccinate Granule, For Suspension
Product Images NDC 52536-134
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin Ethylsuccinate (NDC 52536-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wilshire Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (100 mL Bottle Label)
This is a set of instructions and warnings for a medication containing Erythromycin Ethylsuccinate. The medication is in the form of an oral suspension and contains 4g of Erythromycin per bottle, which can be mixed with 77 ml of water to form a suspension. The medication should be stored at temperatures below 86°F (30°C) and should be refrigerated after mixing. The bottle does not require a child-resistant closure. The text provides dosage instructions for children and adults and advises to refer to enclosed package information for complete instructions.*
Principal Display Panel (200 mL Bottle Label)
This is a description of Erythromycin Ethylsuccinate for Oral Suspension, USP, manufactured by Wilshire Pharmaceuticals, Inc. It contains 200mg of erythromycin when reconstituted with water. It is a cherry-flavored suspension and must be stored below 86°F (30°C) before mixing. After adding water, it yields 200mL of suspension. The usual dose is 30-50mg/kg/day for children, regardless of meals. Full prescribing information is provided in the package enclosure.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.